课题基金 / 基金详情

ACTG250 NEVIRAPINE IN HIV 1 INFECTED PREGNANT WOMEN&NEONATES BORN TO

ACTG250 NEVIRAPINE IN HIV 1 INFECTED PREGNANT WOMEN&NEONATES BORN TO
ACTG250 奈韦拉平治疗 HIV 1 感染孕妇
批准号：
6416324
负责人：
MARGARET A KELLER
金额：
$23.8万
依托单位：
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2000
资助国家：
美国
项目状态：
已结题
起止时间：
2000-12-01 至 2001-11-30
来源：
https://reporter.nih.gov/project-details/6416324
关键词：
AIDS therapy HIV infections clinical research communicable disease control human pregnant subject human subject human therapy evaluation nevirapine vertical transmission virus replication

项目成果

MARGARET A KELLER的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INTENSIVE PHARMACOKINETIC STUDIES OF ANTIRETROVIRAL DRUG COMBINATIONS HIV
INTENSIVE PHARMACOKINETIC STUDIES OF ANTIRETROVIRAL DRUG COMBINATIONS
Two-Dimensional 3 Tesla MRS of the Brain in HIV- Infected Youth
PHARMACOKINETIC PROPERTIES OF ANTIRETROVIRAL THERAPY DURING PREGNANCY
海外基金